![Foto de Guillermo](/img/nophoto.png)
Guillermo
Reglero Rada
Publicaciones en las que colabora con Guillermo Reglero Rada (10)
2015
-
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer
European Journal of Cancer, Vol. 51, Núm. 1, pp. 1-8
-
ColoLipidGene: Signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
Oncotarget, Vol. 6, Núm. 9, pp. 7348-7363
-
Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy
Nutrition and Cancer, Vol. 67, Núm. 8, pp. 1223-1231
-
The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16
Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 2, pp. 433-444
2014
-
Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer
PLoS ONE, Vol. 9, Núm. 6
-
Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer
Molecular Oncology, Vol. 8, Núm. 8, pp. 1469-1481
-
Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
Electrophoresis, Vol. 35, Núm. 11, pp. 1719-1727
2013
-
Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells
Pharmacological Research, Vol. 72, pp. 61-68
-
Supercritical rosemary extracts, their antioxidant activity and effect on hepatic tumor progression
Journal of Supercritical Fluids, Vol. 79, pp. 101-108
2010
-
Nutritional Genomics for the Determination of the Mechanism of Action of the Beneficial Effect of Bioactive Extracts in Tumor Progression
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS